🔎 Trials Near Me

Почетна › Рак на бели дробови со не-мали клетки › Висконсин › Milwaukee

Клинички испитувања за Рак на бели дробови со не-мали клетки во Milwaukee, WI

22 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Milwaukee (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.

Официјален текст на студијата (англиски)

Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Се регрутираФаза 3
  • Froedtert Menomonee Falls Hospital, Menomonee Falls · на 14 милји
  • ProHealth Waukesha Memorial Hospital, Waukesha · на 17 милји
  • UW Cancer Center at ProHealth Care, Waukesha · на 17 милји
  • и уште 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Се регрутираФаза 3
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • и уште 13
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT04267848

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Се регрутираФаза 1
  • Exelixis Clinical Site #33, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT05176483

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Се регрутираФаза 3
  • UW Cancer Center at ProHealth Care, Waukesha · на 17 милји
  • ProHealth D N Greenwald Center, Mukwonago · на 25 милји
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06498635

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Се регрутираФаза 1
  • Research Site, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05877599

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Се регрутираФаза 3
  • Froedtert Hospital/Medical College of Wisconsin, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07222566

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Се регрутираФаза 1
  • Research Site, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06218914

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Се регрутираФаза 3
  • Aurora St. Luke's Medical Center, Milwaukee
  • Aurora Cancer Care-Grafton, Grafton · на 20 милји
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Се регрутираФаза 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • и уште 5
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT03191149

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Се регрутираФаза 3
  • Medical College of Wisconsin, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT06890598

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

Се регрутираФаза 2
  • Medical College of Wisconsin, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 18.9.2026 · NCT06855771

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Се регрутираФаза 1/2
  • Froedtert Hospital - Clinical Cancer Center, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06914128

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Се регрутираФаза 1
  • Medical College of Wisconsin, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06561685

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Се регрутираФаза 3
  • Ascension Columbia St. Mary's, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06793215

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Се регрутираФаза 3
  • Research Site, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 26.8.2026 · NCT06350097

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Се регрутираФаза 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • и уште 4
Возраст 18 и постари · Сите полови · Ажурирано 3.6.2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Се регрутираФаза 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • и уште 5
Возраст 18 и постари · Сите полови · Ажурирано 6.5.2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Се регрутираФаза 2/3
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • и уште 5
Возраст 18 и постари · Сите полови · Ажурирано 5.5.2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Се регрутираНабљудувачка студија
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • и уште 10
Возраст 18 и постари · Сите полови · Ажурирано 17.3.2026 · NCT06418204

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Се регрутира
  • Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 19.2.2026 · NCT02984761

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Се регрутираНабљудувачка студија
  • Massive Bio SYNERGY-AI site, Milwaukee
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)

Се регрутираФаза 2
  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Возраст 18 и постари · Сите полови · Ажурирано 7.10.2025 · NCT06305715

Испитувања за Рак на бели дробови со не-мали клетки во други градови

Други студии во Milwaukee

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.